Insights

Lean culture advantage Darnitsa is actively developing a Lean culture to stay efficient, flexible, and technologically advanced. This presents an opportunity to position scalable collaboration on process improvements, digital solutions, and value-based partnerships that align with their continuous improvement mindset.

Expansion and innovation With a broad portfolio of over 180 medicines and a focus on cardiology, neurology, and pain management, there is potential to expand into related therapeutic areas, manufacturing capabilities, or co-development opportunities to broaden their market reach and product pipeline.

Quality and tech leadership Recognition in SAP Quality Awards and a tech stack spanning SAP, Azure, and cloud tools indicate a mature digital and quality ecosystem. This creates sales opportunities for enterprise software, GMP-compliant solutions, and data analytics platforms that enhance compliance, traceability, and operational efficiency.

Employer brand momentum Being named among Ukraine’s best employers and receiving HR Brand Ukraine awards highlights strong talent attraction and retention. Solutions around workforce analytics, training platforms, and employee engagement tools could support their ongoing people strategy amid expansion and regulatory demands.

Strategic partnerships Active participation in conferences with medical institutions and a global footprint in over 20 countries suggests openness to strategic collaborations, contract manufacturing, and regional distribution partnerships that can accelerate market access and share of shelf in target markets.

Similar companies to Darnytsia

Darnytsia Tech Stack

Darnytsia uses 8 technology products and services including DoubleClick Floodlight, Hotjar, Microsoft Clarity, and more. Explore Darnytsia's tech stack below.

Media & News

Darnytsia's Email Address Formats

Darnytsia uses at least 2 email formats:
Darnytsia Email FormatsExamplePercentage
First.Last@darnitsa.uaJohn.Doe@darnitsa.ua
97%
F.Last@darnitsa.uaJ.Doe@darnitsa.ua
3%

Frequently Asked Questions

What is Darnytsia's official website and social media links?

Minus sign iconPlus sign icon
Darnytsia's official website is darnytsia.ua and has social profiles on LinkedIn.

How much revenue does Darnytsia generate?

Minus sign iconPlus sign icon
As of October 2026, Darnytsia's annual revenue is estimated to be $10M - $25M.

What is Darnytsia's NAICS code?

Minus sign iconPlus sign icon
Darnytsia's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Darnytsia have currently?

Minus sign iconPlus sign icon
As of October 2026, Darnytsia has approximately 385 employees across 3 continents, including Europe, Asia and North America. Key team members include Ceo: A. O., Chief Information Officer: R. B. and Chief Legal Officer: S. B. Explore Darnytsia's employee directory with LeadIQ.

What industry does Darnytsia belong to?

Minus sign iconPlus sign icon
Darnytsia operates in the Pharmaceutical Manufacturing industry.

What technology does Darnytsia use?

Minus sign iconPlus sign icon
Darnytsia's tech stack includes DoubleClick Floodlight, Hotjar, Microsoft Clarity, SAP, Google Workspace, Microsoft 365, DocuSign and Microsoft Azure.

What is Darnytsia's email format?

Minus sign iconPlus sign icon
Darnytsia's email format typically follows the pattern of First.Last@darnitsa.ua. Find more Darnytsia email formats with LeadIQ.

When was Darnytsia founded?

Minus sign iconPlus sign icon
Darnytsia was founded in 1930.
Darnytsia logo

Darnytsia

Pharmaceutical ManufacturingKyiv, Ukraine201-500 Employees

Darnytsia is a Kyiv-based pharmaceutical manufacturer with nearly 95 years of operation, delivering health benefits through a broad portfolio of medicines. The company adheres to Good Manufacturing Practice standards, reflecting its emphasis on quality in production. It manufactures more than 180 medicinal products, with particular focus on cardiology, neurology, and pain management, and it exports to more than 20 countries. 

The organization operates with a mid-sized workforce and has pursued Lean management practices to enhance efficiency and flexibility. In March 2025, amid wartime conditions, Darnytsia introduced 44 new medicines to the market, illustrating ongoing product development.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1930
Employees
201-500

Section iconFunding & Financials

  • $10M - $25M

    Darnytsia's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.